Diabetes, Oncology, Uncategorized 14 Nov 2019 Melatonin supplementation reduces markers of inflammation Melatonin supplementation reduces markers of inflammation This was a meta-analysis of RCTs examining the effect of melatonin supplementation on markers of inflammation. Thirteen trials (of 4 weeks duration or longer,… admin
Oncology 07 Nov 2019 Phase I trial of intratumoral or intraperitoneal bromelain and NAC in patients with mucinous peritoneal tumors Phase I trial of intratumoral or intraperitoneal bromelain and NAC in patients with mucinous peritoneal tumors In this Phase I trial, participants who had either declined surgery for, or were… admin
Diabetes 05 Nov 2019 Melatonin for diabetics receiving dialysis Melatonin leads to improvement in markers of glycemic control, cardiometabolic risk, and oxidative stress in diabetic people receiving dialysis This was a small (N=60) randomized, double-blind placebo controlled trial in… admin